sodium-binding benzofuran isophthalate has been researched along with benzamil in 1 studies
| Studies (sodium-binding benzofuran isophthalate) | Trials (sodium-binding benzofuran isophthalate) | Recent Studies (post-2010) (sodium-binding benzofuran isophthalate) | Studies (benzamil) | Trials (benzamil) | Recent Studies (post-2010) (benzamil) |
|---|---|---|---|---|---|
| 98 | 0 | 10 | 313 | 2 | 74 |
| Protein | Taxonomy | sodium-binding benzofuran isophthalate (IC50) | benzamil (IC50) |
|---|---|---|---|
| Amiloride-sensitive sodium channel subunit alpha | Homo sapiens (human) | 0.066 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mercure, C; Reudelhuber, TL; Touyz, RM | 1 |
1 other study(ies) available for sodium-binding benzofuran isophthalate and benzamil
| Article | Year |
|---|---|
Angiotensin II type I receptor modulates intracellular free Mg2+ in renally derived cells via Na+-dependent Ca2+-independent mechanisms.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Amiloride; Angiotensin II; Animals; Antihypertensive Agents; Benzofurans; Biphenyl Compounds; Calcium; Calcium Channel Agonists; Cell Line; Cells, Cultured; Chelating Agents; Cytosol; Dogs; Dose-Response Relationship, Drug; Egtazic Acid; Ethers, Cyclic; Fluorescent Dyes; Fura-2; Imidazoles; Imipramine; Irbesartan; Kidney; Kinetics; Magnesium; Microscopy, Fluorescence; Peptides; Pyridines; Quinidine; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium; Tetrazoles; Time Factors | 2001 |